Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 271 AL 285

Low-Level Laser Therapy to the Bone Marrow Ameliorates Neurodegenerative Disease Progression in a Mouse Model of Alzheimer's Disease: A Minireview

Oron A, Oron U.

Photomed Laser Surg. 2016 Dec;34(12):627-630. doi: 10.1089/pho.2015.4072. Epub 2016 Jun 13.

Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond

Cuyvers E, Sleegers K.

Lancet Neurol. 2016 Jul;15(8):857-868. doi: 10.1016/S1474-4422(16)00127-7.

Can 'calpain-cathepsin hypothesis' explain Alzheimer neuronal death?

Yamashima T.

Ageing Res Rev. 2016 Dec;32:169-179. doi: 10.1016/j.arr.2016.05.008. Epub 2016 Jun 13.

Drug Development of Small-Molecule Inhibitors of AD-Relevant Kinases as Novel Perspective Multitargeted Approach

Tell V, Hilbrich I, Holzer M, Totzke F, Schachtele C, Slynko I, Sippl W, Hilgeroth A.

Curr Alzheimer Res. 2016;13(12):1330-1336. doi: 10.2174/1567205013666160615091821.

Inflammasome Involvement in Alzheimer's Disease

Olsen I, Singhrao SK.

J Alzheimers Dis. 2016 Jun 15;54(1):45-53. doi: 10.3233/JAD-160197.

Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review)

Li X, Bao X, Wang R.

Mol Med Rep. 2016 Aug;14(2):1043-53. doi: 10.3892/mmr.2016.5390. Epub 2016 Jun 10.

Alzheimer's secretase enzymes: Cell biology, regulation, function and therapeutic potential

Ohno M.

Brain Res Bull. 2016 Sep;126(Pt 2):153. doi: 10.1016/j.brainresbull.2016.06.003. Epub 2016 Jun 15.

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?

Pivovarova O, Höhn A, Grune T, Pfeiffer AF, Rudovich N.

Ann Med. 2016 Dec;48(8):614-624. doi: 10.1080/07853890.2016.1197416. Epub 2016 Jun 19.

Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases

Jung HA, Ali MY, Jung HJ, Jeong HO, Chung HY, Choi JS.

J Ethnopharmacol. 2016 Sep 15;191:152-160. doi: 10.1016/j.jep.2016.06.037. Epub 2016 Jun 15.

Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease

Taniguchi N, Takahashi M, Kizuka Y, Kitazume S, Shuvaev VV, Ookawara T, Furuta A.

Glycoconj J. 2016 Aug;33(4):487-97. doi: 10.1007/s10719-016-9690-2. Epub 2016 Jun 21.

Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis

Luo J, Wärmländer SK, Gräslund A, Abrahams JP.

J Biol Chem. 2016 Aug 5;291(32):16485-93. doi: 10.1074/jbc.R116.714576. Epub 2016 Jun 20.

Alzheimer's disease, menopause and the impact of the estrogenic environment

Pines A.

Climacteric. 2016 Oct;19(5):430-2. doi: 10.1080/13697137.2016.1201319. Epub 2016 Jun 21.

Alzheimer's disease due to loss of function: A new synthesis of the available data

Kepp KP.

Prog Neurobiol. 2016 Aug;143:36-60. doi: 10.1016/j.pneurobio.2016.06.004. Epub 2016 Jun 18.

Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease

Love S, Miners JS.

Brain Pathol. 2016 Sep;26(5):607-17. doi: 10.1111/bpa.12401.

Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine

Cardoso S, Carvalho C, Correia SC, Seiça RM, Moreira PI.

Brain Pathol. 2016 Sep;26(5):632-47. doi: 10.1111/bpa.12402.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias